The pathway of ICD-induced tumour cell death relies on damage-associated molecular patterns (DAMPs) such as heat shock proteins (HSPs), high mobility group box 1 (HMGB1) and calreticulin (CRT), making tumour cells a “therapeutic vaccine” that can induce anti-tumour immunity (86). The gene discussed is CALR; the disease is neoplasm.